文献速递腹部技术与安全PETCT

68Ga-FAPI-04 PET/CT与18F-FDG PET/CT在结直肠癌中诊断性能的头对头比较:系统评价与Meta分析

Head-to-head comparison of the diagnostic performance between 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT in colorectal cancer: a systematic review and meta-analysis.
PubMed 文献 · Abdom Radiol (NY) · 2024-04-08

该系统评价与Meta分析共纳入8项研究,比较68Ga-FAPI-04 PET/CT与18F-FDG PET/CT在结直肠癌中的检出率。68Ga-FAPI-04 PET/CT在淋巴结转移(RR=0.63,95%CI 0.47-0.84,P=0.002)和腹膜转移(RR=0.52,95%CI 0.32-0.85,P=0.009)的病灶检出率优于18F-FDG PET/CT,两者在原发肿瘤的诊断效能基本相同(RR=0.99,95%CI 0.96-1.02,P=0.49)。

要点

  • 68Ga-FAPI-04 PET/CT在淋巴结转移和腹膜转移的病灶检出率优于18F-FDG PET/CT。
  • 两种示踪剂在原发肿瘤的诊断效能基本相同(RR=0.99,95%CI 0.96-1.02,P=0.49)。
  • 68Ga-FAPI-04 PET/CT在淋巴结、骨和腹膜转移中摄取高于18F-FDG PET/CT。

核心结论

  • 68Ga-FAPI-04作为一种高度有前景的PET/CT示踪剂,在结直肠癌中优于18F-FDG PET/CT,尤其在检测淋巴结转移和腹膜转移方面。

研究设计与样本

  • 系统评价与Meta分析,检索截至2023年9月的主要医学数据库,共纳入8项研究,采用随机效应模型计算合并风险比(RR)及95%CI以校正异质性。

关键影像表现/征象

  • 68Ga-FAPI-04 PET/CT在淋巴结、骨和腹膜转移中摄取高于18F-FDG PET/CT。

诊断标准与关键数值

  • 基于病灶的检出率:淋巴结转移RR=0.63(95%CI 0.47-0.84,P=0.002),腹膜转移RR=0.52(95%CI 0.32-0.85,P=0.009),原发肿瘤RR=0.99(95%CI 0.96-1.02,P=0.49)。

临床应用与阅片要点

  • 作者认为68Ga-FAPI-04 PET/CT在结直肠癌中优于18F-FDG PET/CT,尤其在检测淋巴结转移和腹膜转移方面。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This study aimed to compare the detection rates of 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT in colorectal cancer. A systematic search of major medical databases was conducted to identify studies up to September 2023. The primary outcome assessed was the detection rate of 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT in the primary tumor. Pooled risk ratios with a 95% CI were calculated using random-effect models to adjust for heterogeneity. Eight studies were included in the meta-analysis. 68Ga-FAPI-04 PET/CT has higher uptakes in lymph nodes, bone, and peritoneal metastasis compared with 18F-FDG PET/CT. The detection rate of 68Ga-FAPI-04 PET/CT based on lesion was better for lymph node metastasis (RR = 0.63, 95% CI 0.47-0.84, P = 0.002) and peritoneal metastasis (RR = 0.52, 95% CI 0.32-0.85, P = 0.009), both imaging modalities had essentially the same diagnostic efficacy in primary tumor (RR = 0.99, 95% CI 0.96-1.02, P = 0.49). 68Ga-FAPI-04 as a highly promising PET/CT tracer was superior to 18F-FDG PET/CT in colorectal cancer, especially in detecting lymph node metastases and peritoneal metastases.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Zhuang Z, Zhang Y, Yang X, et al. Head-to-head comparison of the diagnostic performance between 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT in colorectal cancer: a systematic review and meta-analysis. Abdom Radiol (NY). 2024. PMID: 38587629. doi:10.1007/s00261-024-04266-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。